Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pain and Major Depressive Disorder

NCT: NCT04556890 · RECRUITING

NCT IDNCT04556890
StatusRECRUITING
Start Date2023-03-01
Completion2027-12-31
SponsorUniversity of California, Los Angeles (OTHER)
First posted
Last updated

Brief Summary

This study will examine the effects of brain stimulation on pain symptoms associated with Major depressive disorder. This study will enroll 54 Subjects. Study subjects will be asked to complete surveys about their mood and well-being, 2 blood draws, 2 MRIs, 3 electroencephalograms, and receive 30 treatments of blinded transcranial magnetic stimulation. There is no control group as all subjects will receive some form of active treatment. Subjects are required to participate in 30-33 study visits and volunteer 40 hours of their time. Compensation for this study is $150 for completing all study activities.

Frequently Asked Questions

What is Pain and Major Depressive Disorder?

Pain and Major Depressive Disorder is a clinical trial registered under NCT04556890. Current status: RECRUITING.

What is the status of NCT04556890?

The current status of NCT04556890 (Pain and Major Depressive Disorder) is: RECRUITING.

When did Pain and Major Depressive Disorder start?

Pain and Major Depressive Disorder started on 2023-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.